María Alejandra Mateo-Vargas

Ms. María Alejandra Mateo-Vargas

Universidad de Cádiz, Spain
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 July 2021 in Foods
Verified
Journal Article
Open access
PDF file
ALESSANDRA DI CANITOALESSANDRA DI CANITO
ALESSANDRA DI CANITO
MMMaría Alejandra Mateo-Vargas
María Alejandra Mateo-Vargas
MMMonica Mazzieri
Monica Mazzieri
JFJesús Manuel Cantoral Fernández
Jesús Manuel Cantoral Fernández
Roberto FoschinoRoberto Foschino
Roberto Foschino
Ileana VigentiniIleana Vigentini
Ileana Vigentini
In view of the growing concern about the impact of synthetic fungicides on human health and the environment, several government bodies have decided to ban them. As a result, a great number of studies have been carried out in recent decades with the aim of finding a biological alternative to inhibit the growth of fungal pathogens. In order to avoid the large losses of fruit and vegetables that these pathogens cause every year, the biological alternative’s efficacy should be the same as that of a chemical pesticide. In this review, the main studies discussed concern Saccharomyces and non-Saccharomyces yeasts as potential antagonists against phytopathogenic fungi of the genera Penicillium and Aspergillus and the species Botrytis cinerea on table grapes, wine grapes, and raisins.

4 June 2025 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Open access
MMMaría Alejandra Mateo-Vargas
María Alejandra Mateo-Vargas
SRSalud Rodríguez-Pallares
Salud Rodríguez-Pallares
JAJorge Arca-Suárez
Jorge Arca-Suárez
LLLorena López-Cerero
Lorena López-Cerero
MRManuel Rodríguez-Iglesias
Manuel Rodríguez-Iglesias
FGFátima Galán-Sánchez
Fátima Galán-Sánchez
De novo infections caused by ceftazidime/avibactam-resistant KPC variants are rarely reported. We characterize the evolution of a KPC-8-producing Klebsiella pneumoniae strain involved in a primary infection without previous ceftazidime/avibactam treatment. During a 15-month follow-up, changes in carbapenem susceptibility due to porin alterations were observed, remaining susceptible to meropenem/vaborbactam, imipenem/relebactam, and cefiderocol. High- and low-permeability recombinant Escherichia coli isolates analysis revealed that, unlike the widespread ceftazidime/avibactam-resistant variant KPC-31, KPC-8 confers ceftazidime/avibactam resistance without decreasing carbapenemase activity.

15 September 2023 in Microbes and Infection
Verified
Journal Article
Closed access
SRSalud Rodríguez-Pallares
Salud Rodríguez-Pallares
MMMaría Alejandra Mateo-Vargas
María Alejandra Mateo-Vargas
MRManuel A. Rodríguez-Iglesias
Manuel A. Rodríguez-Iglesias
FGFátima Galán-Sánchez
Fátima Galán-Sánchez

3 June 2026 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Open access
MMMaría Alejandra Mateo-Vargas
María Alejandra Mateo-Vargas
FFFelipe Fernández-Cuenca
Felipe Fernández-Cuenca
LLLorena López-Cerero
Lorena López-Cerero
MRManuel A Rodriguez-Iglesias
Manuel A Rodriguez-Iglesias
FGFátima Galán-Sánchez
Fátima Galán-Sánchez
Chromosomal tandem duplications are scarcely reported in Klebsiella pneumoniae . We describe a chromosomal fosA6 tandem multicopy fragment present at varying copy number in five consecutive K. pneumoniae carbapenemase-producing K. pneumoniae isolates recovered from a single patient over 27 months. Fosfomycin minimum inhibitory concentrations increased with copy number; however, fosA6 expression did not scale proportionally with copy number. No other fosfomycin resistance mechanism was identified. This highlights the clinical relevance of chromosomal AMR gene amplifications.